T1	OrganismPart 0 5	Brain
T3	Modification 212 216	DPMs
T2	Modification 176 210	degenerative protein modifications
*	Equiv T2 T3
T4	Disease 107 155	Alzheimer's disease with cerebrovascular disease
T5	Disease 354 362	AD + CVD
*	Equiv T4 T5
A1	Modification T2 variable
A2	Modification T3 variable
T6	Organism 687 692	human
T7	Modification 710 721	ureido DPMs
T8	Modification 723 728	uDPMs
A3	Modification T8 variable
A4	Modification T7 variable
T9	FractionationMethod 1012 1094	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography
T10	FractionationMethod 1096 1104	UC-ERLIC
*	Equiv T9 T10
T11	SamplingTime 1227 1237	postmortem
T12	OrganismPart 1238 1253	brain fractions
T13	Modification 730 753	arginine citrullination
A5	Modification T13 fixed
T14	Modification 758 778	lysine carbamylation
A6	Modification T14 fixed
T15	FractionationFraction 1203 1226	soluble and particulate
T16	MaterialType 8031 8044	Sigma-Aldrich
T17	CleavageAgent 8182 8215	sequencing-grade-modified trypsin
T18	MaterialType 8235 8242	Promega
T19	SampleTreatment 8094 8129	Protease inhibitor cocktail tablets
T20	MaterialType 8150 8155	Roche
T22	SupplementaryFile 8728 8755	Additional file 1: Table S1
T23	Age 8678 8681	age
R1	IsInSuppl Arg1:T23 Arg2:T22	
T24	Sex 8705 8710	gende
R2	IsInSuppl Arg1:T24 Arg2:T22	
T25	SamplingTime 8683 8700	postmortem delay,
R3	IsInSuppl Arg1:T25 Arg2:T22	
T26	BiologicalReplicate 8757 8762	Three
T27	FractionationFraction 11406 11429	Soluble and particulate
T28	FractionationFraction 10343 10366	Soluble and particulate
T29	FractionationMethod 10423 10516	ultracentrifugation-electrostatic repulsion hydrophilic interaction chromatography (UC-ERLIC)
T30	Instrument 15295 15327	Orbitrap Elite mass spectrometer
T31	Instrument 15343 15376	Dionex UltiMate 3000 UHPLC system
T32	Separation 15485 15524	reverse phase Acclaim PepMap RSL column
T33	Temperature 15611 15622	35 degreesC
T34	FlowRateChromatogram 15648 15659	0.3 muL/min
T35	FlowRateChromatogram 15690 15705	60-min gradient
T21	OrganismPart 8367 8387	middle temporal lobe
T36	OrganismPart 8389 8400	BA21 region
T37	IonizationType 16172 16230	Michrom's Thermo Captive Spray nanoelectrospray ion source
T38	FragmentationMethod 16799 16841	high-energy collisional dissociation (HCD)
T39	CollisionEnergy 16852 16883	32% normalized collision energy
T40	Modification 17294 17335	Carbamidomethylation of cysteine residues
A7	Modification T40 fixed
T41	NumberOfSamples 8655 8662	samples
R4	IsInSuppl Arg1:T41 Arg2:T22	
T42	FragmentMassTolerance 17184 17190	10 ppm
T43	FragmentMassTolerance 17195 17202	0.05 Da
T44	EnrichmentMethod 18241 18248	FunRich
T45	Temperature 11969 11980	30 degreesC
T46	Time 11981 11990	overnight
T47	OutOfScope 11994 12030	1:20 (w/w) enzyme-to-substrate ratio
T48	AcquisitionMethod 16382 16410	Xcalibur 2.2 SP1.48 software
T49	AcquisitionMethod 16341 16354	positive mode
T50	AcquisitionMethod 16515 16555	full Fourier transform-mass spectrometry
